Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 randomized double-blind placebo-controlled trial of NBP injection for acute ischemic stroke
ChiCTR-TRC-12003394Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital, Department of Neurology
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of butylphthalide in ischemic stroke and brain infarction (2 arms), sponsored by Peking Union Medical College Hospital, Department of Neurology. Primary endpoints: Modified Rankin Scale responder rate, NIHSS score and 1 more. Started Aug 2012; status: completed.
02
Drugs
butylphthalide
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on ChiCTR-TRC-12003394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12003394.